These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 876340)

  • 1. Lower doses of factor VIII for hemophilia.
    Penner JA; Kelly PE
    N Engl J Med; 1977 Aug; 297(7):401. PubMed ID: 876340
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of hemophilia].
    De Tezanos Pinto M
    Medicina (B Aires); 1968 Dec; 28():Suppl 1:27-33. PubMed ID: 5730274
    [No Abstract]   [Full Text] [Related]  

  • 3. Editorial: Home therapy for haemophilia.
    Br Med J; 1975 Feb; 1(5955):417. PubMed ID: 1115959
    [No Abstract]   [Full Text] [Related]  

  • 4. Early treatment of hemophilic hemarthroses with minimal dose of new factor 8 concentrate.
    Britton M; Harrison J; Abildgaard CF
    J Pediatr; 1974 Aug; 85(2):245-7. PubMed ID: 4842798
    [No Abstract]   [Full Text] [Related]  

  • 5. Factor VIII usage in the Wisconsin Hemophilia Program; factor VIII usage in hemophilia.
    Lange D; Lazerson J
    Wis Med J; 1982 Feb; 81(2):28-31. PubMed ID: 6803446
    [No Abstract]   [Full Text] [Related]  

  • 6. Even more concentrated antihaemophilic globulin.
    Lancet; 1968 Nov; 2(7579):1176-7. PubMed ID: 4176953
    [No Abstract]   [Full Text] [Related]  

  • 7. Including the life-time cumulative number of joint bleeds in the definition of primary prophylaxis.
    den Uijl IE; Fischer K
    Thromb Haemost; 2008 May; 99(5):965; author reply 966-8. PubMed ID: 18449430
    [No Abstract]   [Full Text] [Related]  

  • 8. Relationship between factor VIII replacement therapy and joint damage in severe haemophilia.
    Lowe GD
    Blood Coagul Fibrinolysis; 1997 Aug; 8 Suppl 1():S3-5. PubMed ID: 9351528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cryoprecipitate and the use of the plastic blood bag system in the management of haemophilia and other coagulation disorders.
    Dormandy KM
    Proc R Soc Med; 1968 Jun; 61(6):595-8. PubMed ID: 5301887
    [No Abstract]   [Full Text] [Related]  

  • 10. Haemophilia.
    Jones P
    Physiotherapy; 1976 Jun; 62(7):214-6. PubMed ID: 967940
    [No Abstract]   [Full Text] [Related]  

  • 11. The management of bleeding in hemophilia.
    Abildgaard CF
    Adv Pediatr; 1969; 16():365-90. PubMed ID: 4899062
    [No Abstract]   [Full Text] [Related]  

  • 12. The safety and efficacy of B-domain deleted recombinant factor VIII concentrates in patients with severe haemophilia A: an update.
    Lusher JM; Roth DA
    Haemophilia; 2005 May; 11(3):292-3. PubMed ID: 15876278
    [No Abstract]   [Full Text] [Related]  

  • 13. Haemarthrosis and haemophilia.
    Sterndale H
    Proc R Soc Med; 1967 Jan; 60(1):37-8. PubMed ID: 6018478
    [No Abstract]   [Full Text] [Related]  

  • 14. Prophylactic treatment for prevention of joint disease in hemophilia--cost versus benefit.
    Roosendaal G; Lafeber F
    N Engl J Med; 2007 Aug; 357(6):603-5. PubMed ID: 17687136
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hemophilia, a changed picture].
    Breederveld C; ten Cate JW; Sixma JJ; Veltkamp JJ
    Ned Tijdschr Geneeskd; 1976 Jan; 120(2):69-70. PubMed ID: 1250448
    [No Abstract]   [Full Text] [Related]  

  • 16. Double-blind studies on the use of steroids in the treatment of acute hemarthrosis in patients with hemophilia.
    Kisker CT; Burke C
    N Engl J Med; 1970 Mar; 282(12):639-42. PubMed ID: 4907066
    [No Abstract]   [Full Text] [Related]  

  • 17. Hemophilia with factor VIII inhibitor. Elimination of anamnestic response.
    Stein RS; Colman RW
    Ann Intern Med; 1973 Jul; 79(1):84-7. PubMed ID: 4124485
    [No Abstract]   [Full Text] [Related]  

  • 18. Low doses of factor VIII for selected ankle bleeds in severe haemophilia A.
    Aronstam A; Wassef M; Hamad Z
    Br Med J (Clin Res Ed); 1982 Mar; 284(6318):790. PubMed ID: 6802229
    [No Abstract]   [Full Text] [Related]  

  • 19. Best evidence on B-domain deletion and the immunogenicity of recombinant factor VIII.
    Aledort LM; Navickis RJ; Wilkes MM
    J Thromb Haemost; 2011 Nov; 9(11):2325-7. PubMed ID: 21880112
    [No Abstract]   [Full Text] [Related]  

  • 20. [Perioperative management of orthopaedic patients with hemophilia A].
    Wu YG; Li XG; Zhang KN; Ren YJ; Li SF; Lu MY
    Zhonghua Wai Ke Za Zhi; 2004 Dec; 42(23):1430-3. PubMed ID: 15733456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.